Diabetes

Xeris’ severe low blood sugar pen gets FDA approval

https://pharmaphorum.com/news/xeris-severe-low-blood-sugar-pen-gets-fda-approval/

North American Prefilled Syringes Market to achieve 10% CAGR up to 2025

https://pharmaphorum.com/partner-content/north-american-prefilled-syringes-market-to-achieve-10-cagr-up-to-2025/

Mylan’s Lantus biosimilar held up by manufacturing issue

https://pharmaphorum.com/news/mylans-lantus-biosimilar-held-up-by-manufacturing-issue/

Heart failure results could unlock key market for Farxiga – AZ

https://pharmaphorum.com/news/heart-failure-results-could-unlock-key-market-for-farxiga-az/

FDA fast-tracks AZ’s Farxiga in potential new CKD indication

https://pharmaphorum.com/news/fda-fast-tracks-azs-farxiga-in-potential-new-ckd-indication/

AZ’s Farxiga first in class to improve outcomes in heart failure

https://pharmaphorum.com/news/azs-farxiga-first-in-class-to-improve-outcomes-in-heart-failure/

Novo Nordisk faces $1.8 billion lawsuit over US insulin sales

https://pharmaphorum.com/news/novo-nordisk-faces-1-8-billion-lawsuit-over-us-insulin-sales/

NHS patients to receive digital diabetes prevention support

https://pharmaphorum.com/news/nhs-patients-to-receive-digital-diabetes-support/

Novo extends R&D alliance with AI specialist e-Therapeutics

https://pharmaphorum.com/news/novo-extends-rd-alliance-with-ai-specialist-e-therapeutics/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search